CONSISTENCY OF CLINICAL RESPONSE TO RECOMBINANT HUMAN PARATHYROID HORMONE (1-84) (RHPTH[1-84]) AMONG PATIENTS WITH HYPOPARATHYROIDISM

被引：0
|
作者：
Chen, K. [1 ]
Li, N. [2 ]
Gao, W. [2 ]
Zhao, J. [2 ]
Signorovitch, J. [2 ]
机构：
[1] Shire Human Genet Therapies Inc, Lexington, MA USA
[2] Anal Grp Inc, Boston, MA USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY10
引用
收藏
页码：A210 / A210
页数：1
相关论文
共 50 条
  • [1] Hypoparathyroidism treated with recombinant human parathyroid hormone [rhPTH(1-84)]
    Ramacciotti, Constanza F.
    Celina Pereyra, M.
    Cohen, Eduardo N.
    [J]. MEDICINA-BUENOS AIRES, 2020, 80 (03) : 289 - 291
  • [2] Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism
    Kim, Esther S.
    Keating, Gillian M.
    [J]. DRUGS, 2015, 75 (11) : 1293 - 1303
  • [3] REPLACEMENT THERAPY WITH RECOMBINANT PARATHYROID HORMONE (1-84) IN HYPOPARATHYROIDISM
    Galoiu, S.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2015, 11 (03) : 413 - 414
  • [4] Renal Function Change in Chronic Hypoparathyroidism Patients Treated With Recombinant Human Parathyroid Hormone (1-84) (rhPTH[1-84]) and in a Historical Control Cohort Treated With Standard Therapy
    Chen, Kristina
    Rubin, Mishaela
    Mu, Fan
    Swallow, Elyse
    Zhao, Jing
    Wang, Jessie
    Krasner, Alan
    Sherry, Nicole
    Signorovitch, James
    Ketteler, Markus
    Bilezikian, John
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 199 - 199
  • [5] Recombinant human parathyroid hormone (1-84) replacement therapy in a child with hypoparathyroidism
    Laurer, Elisabeth
    Gruenberger, Johanna
    Naidoo, Uvistra
    Lanzersdorfer, Roland
    Wimleitner, Marlene
    Tischlinger, Katharina
    Hoegler, Wolfgang
    [J]. BONE, 2021, 144
  • [6] Extended Treatment With Recombinant Human Parathyroid Hormone (1-84) in Adult Patients With Chronic Hypoparathyroidism
    Rubin, Mishaela R.
    Cusano, Natalie
    Yin, Shaoming
    Tokareva, Elena
    Ayodele, Olulade
    Finkelman, Richard D.
    [J]. ENDOCRINE PRACTICE, 2024, 30 (03) : 200 - 208
  • [7] Recombinant human parathyroid hormone (1-84) is effective in CASR-associated hypoparathyroidism
    Hawkes, Colin Patrick
    Shulman, Dorothy, I
    Levine, Michael A.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2020, 183 (06) : K13 - K21
  • [8] The effects of recombinant human parathyroid hormone, rhPTH(1-84), on bone mass in undernourished rats
    Rhee, Y
    Namgung, R
    Park, DH
    Lee, HC
    Huh, GB
    Lim, SK
    [J]. JOURNAL OF ENDOCRINOLOGY, 2002, 174 (03) : 419 - 425
  • [9] AN OPEN-LABEL EXTENSION STUDY OF PARATHYROID HORMONE RHPTH(1-84) IN ADULTS WITH HYPOPARATHYROIDISM
    Lakatos, Peter
    Bajnok, Laszlo
    Lagast, Hjalmar
    Valkusz, Zsuzsanna
    [J]. ENDOCRINE PRACTICE, 2016, 22 (05) : 523 - 532
  • [10] Safety, tolerability and pharmacokinetic study of recombinant human parathyroid hormone [rhPTH (1-84)] in Chinese healthy volunteers
    Li, Qian
    Qiao, Jian
    Deng, Jungang
    Zeng, Tianshu
    Zhou, Piqi
    Li, Weiyong
    [J]. JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2009, 29 (04) : 431 - 434
12345